Neuroprotective effect and brain receptor binding of taltirelin, a novel thyrotropin-releasing hormone (TRH) analogue, in transient forebrain ischemia of C57BL/6J mice

Life Sciences

Volumn 72, Issue 4-5, 2002, Pages 601-607

  Urayama, Akihiko ^a   Yamada, Shizuo ^a   Kimura, Ryohei ^a   Zhang, Jun ^b   Watanabe, Yasuo ^c  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b Synapse Co   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Brain receptor binding; Delayed neuronal death; Ischemia; Taltirelin; TRH

Indexed keywords

BRAIN RECEPTOR; PROTIRELIN DERIVATIVE; SUCROSE; TALTIRELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD BRAIN BARRIER; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CELL DENSITY; CONFERENCE PAPER; CONTROLLED STUDY; DISSOCIATION CONSTANT; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; FOREBRAIN; HIPPOCAMPUS; MALE; MOUSE; MOUSE STRAIN; NERVE CELL; NEUROPROTECTION; NONHUMAN; REPERFUSION; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CELL COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; ISCHEMIC ATTACK, TRANSIENT; MALE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; NOOTROPIC AGENTS; RECEPTORS, THYROTROPIN-RELEASING HORMONE; REPERFUSION INJURY; SUCROSE; THYROTROPIN-RELEASING HORMONE;

ANIMALIA;

EID: 0037147052     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02268-3     Document Type: Conference Paper

References (24)

1. Faden A.I. Pharmacological treatment of central nervous system trauma. Pharmacology and Toxicology. 78(1):1996;12-17.
2. Fukuchi I., Asahi T., Kawashima K., Kawashima Y., Yamamura M., Matsuoka Y., Kinoshita K. Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain. Arzneimittelforschung. 48(4):1998;353-359.
3. Horita A. An update on the CNS actions of TRH and its analogs. Life Sciences. 62(17-18):1998;1443-1448.
4. A receptors. Acta Anaesthesiologia Scandinavica. 43(2):1999;153-162.
5. Iwasaki Y., Ikeda K., Shiojima T., Kinoshita M. TRH analogue, TA-0910 (3-methyl-(s)-5,6-dihydroorotyl-L-histidyl-L-prolinamide) enhances neurite outgrowth in rat embryo ventral spinal cord in vitro. Journal of the Neurological Sciences. 112(1-2):1992;147-151.
6. Keller H.H., Bartholini G., Pletscher A. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone. Nature. 248(448):1974;528-529.
7. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry. 193(1):1951;265-275.
8. Manaka S., Fuchinoue T., Kondo T., Hori T., Sano K. Effects of thyrotropin-releasing hormone tartrate on consciousness disturbance-preliminary report. Brain and Nerve. 29(10):1977;1075-1081.
9. Manaker S., Winokur A., Rostene W.H., Rainbow T. Autoradiographic localization of thyrotropin-releasing hormone receptors in the rat central nervous system. Journal of Neuroscience. 5(1):1985;167-174.
10. Patapoutian A., Reichardt L.F. Trk receptors: mediators of neurotrophin action. Current Opinion in Neurobiology. 11(3):2001;272-280.
11. Pizzi M., Boroni F., Benaresa M., Moraitis C., Memo M., Spano P. Neuroprotective effect of thyrotropin-releasing hormone against excitatory amino acid-induced cell death in hippocampal slices. European Journal of Pharmacology. 370(2):1999;133-137.
12. Sharif N.A., To Z.P., Whiting R.L. Analogs of thyrotropin-releasing hormone (TRH): receptor affinities in brains, spinal cords, and pituitaries of different species. Neurochemical Research. 16(2):1991;95-103.
13. Shishido Y., Furushiro M., Tanabe S., Shibata S., Hashimoto S., Yokokura T. Effects of prolyl endopeptidase inhibitors and neuropeptides on delayed neuronal death in rats. European Journal of Pharmacology. 372(2):1999;135-142.
14. Smith J., Yu R., Hinkle P.M. Activation of MAPK by TRH requires clathrin-dependent endocytosis and PKC but not receptor interaction with beta-arrestin or receptor endocytosis. Molecular Endocrinology. 15(9):2001;1539-1548.
15. Urayama A., Yamada S., Deguchi Y., Kimura R., Maeda Y., Kobayashi T. Brain receptor binding characteristics and pharmacokinetics of JTP-2942, a novel thyrotropin-releasing hormone (TRH) analogue. Life Sciences. 65(22):1999;2407-2415.
16. Urayama A., Yamada S., Hirano K., Deguchi Y., Kimura R. Brain receptor binding characteristics and pharmacokinetic-pharmacodynamic analysis of thyrotropin-releasing hormone analogues. Life Sciences. 70(6):2001;647-657.
17. Wellons J.C., Sheng H., Laskowitz D.T., Burkhard Mackensen G., Pearlstein R.D., Warner D.S. A comparison of strain-related susceptibility in two murine recovery models of global cerebral ischemia. Brain Research. 868(1):2000;14-21.
18. 3H]WB4101: effect of 6-hydroxydopamine treatment. Journal of Pharmacology and Experimental Therapeutics. 215(1):1980;176-185.
19. Yamada S., Uchida S., Naito T., Urayama A., Kimura R., Murakami Y., Matsumoto K., Watanabe H. Increase in receptor binding affinity for nimodipine in the rat brain with permanent occlusion of bilateral carotid arteries. Life Sciences. 66(14):2000;1351-1357.
20. Yamamura M., Kinoshita K., Nakagawa H., Tanaka T., Maeda K., Ishida R. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog, (I): Effects on the central nervous system by oral administration. Japanese Journal of Pharmacology. 53(4):1990;451-461.
21. Yamamura M., Kinoshita K., Nakagawa H., Ishida R. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (III): Inhibition of pentobarbital anesthesia. Japanese Journal of Pharmacology. 55(1):1991;69-80.
22. Yang G., Kitagawa K., Matsushita K., Mabuchi T., Yagita Y., Yanagihara T., Matsumoto M. C57BL/6 strain is most susceptible to cerebral ischemia following bilateral common carotid occlusion among seven mouse strains: selective neuronal death in the murine transient forebrain ischemia. Brain Research. 752(1-2):1997;209-218.
23. Lin W.W., Wang C.W., Chuang D.M. Effect of depolarization and NMDA antagonists on the survival of cerebellar granule cells: a pivotal role for protein kinase C isoforms. Journal of Neurochemistry. 68(6):1997;2577-2586.
24. Lucas M., Sanchez-Margalet V., Sanz A., Solano F. Protein kinase C activation promotes cell survival in mature lymphocytes prone to apoptosis. Biochemical Pharmacology. 47(4):1994;667-672.